Abstract
Hemochromatosis is a disease defined by iron overload. Hereditary hemochromatosis is an autosomal recessive disease with a prevalence of 2 per 1,000 in those of European ancestry. It most commonly presents with liver disease but can also affect many other organ systems.
Gastrointestinal symptoms often include:
Abdominal pain
Symptoms related to complications of cirrhosis and portal hypertension
Hepatomegaly
Cirrhosis/end-stage liver disease with portal hypertension
Ascites/fluid retention
Esophageal/rectal varices
Portal hypertensive gastropathy
Hemorrhagic diathesis
Hepatic encephalopathy
Diabetes mellitus/“bronze diabetes”
Cardiomyopathy
Impotence from hypogonadotropic hypogonadism due to pituitary involvement
Development of hepatocellular carcinoma
Elevated aminotransferase levels
The pathogenesis is based on genetic mutations that affect transport of iron. The most common involve HFE, a regulator of hepcidin, the major serum signaling protein
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Hemochromatosis is a disease defined by iron overload. Hereditary hemochromatosis is an autosomal recessive disease with a prevalence of 2 per 1,000 in those of European ancestry. It most commonly presents with liver disease but can also affect many other organ systems [1].
Gastrointestinal symptoms often include [1]:
-
Abdominal pain
-
Symptoms related to complications of cirrhosis and portal hypertension
-
Hepatomegaly
-
Cirrhosis/end-stage liver disease with portal hypertension
-
Ascites/fluid retention
-
Esophageal/rectal varices
-
Portal hypertensive gastropathy
-
Hemorrhagic diathesis
-
Hepatic encephalopathy
-
-
Diabetes mellitus/“bronze diabetes”
-
Cardiomyopathy
-
Impotence from hypogonadotropic hypogonadism due to pituitary involvement
-
Development of hepatocellular carcinoma
-
Elevated aminotransferase levels
The pathogenesis is based on genetic mutations that affect transport of iron. The most common involve HFE, a regulator of hepcidin, the major serum signaling protein [2–4]
-
Autosomal recessive
-
Mutation of HFE gene
-
Homozygous at C282Y (80% of cases have mutations at this locus)
-
Compound heterozygote mutation of C282Y and H63D plus another risk factor for iron overload
-
Homozygous H63D not clinically significant for development of iron overload
-
Leads to inappropriately high levels of iron absorption and deposition in the liver and other organs
-
The pathology of iron overload of the liver can show [1]:
-
Liver biopsy (see Fig. 71.1)
-
Two to 4+ or more hepatocellular iron stores on staining with higher density in the periportal area
-
Severe iron storage shows 4+ staining with fibrosis
-
Hepatic iron index of 1.9 μmol/g/year
-
Hepatic iron concentration of >71 μmol/g/dry weight
-
The diagnosis is made with [1]:
-
Transferrin saturation >45%
-
Elevated ferritin
-
C282Y and H63D mutation genetic testing
-
Abnormal liver enzymes
-
Hepatomegaly
-
Liver biopsy
-
Hepatic magnetic resonance imaging
The differential diagnosis of hemochromatosis should include [1]:
-
Secondary iron overload
-
Sideroblastic anemia
-
Thalassemia major
-
Sickle cell anemia
-
Excess alcohol consumption
-
Parenteral iron overload from transfusions
-
-
Nonalcoholic steatohepatitis
The treatment involves removal of iron and reduction of iron body stores [1]:
-
Phlebotomy to remove excess iron stores performed weekly until
-
Ferritin is <50 ng/mL
-
Transferrin iron saturation <50%
-
-
Chelation with deferoxamine, deferasirox, or deferiprone, if anemia and iron overload are present concomitantly
-
Avoidance of vitamin C, which enhances iron toxicity
-
Liver transplant; screen for hepatocellular carcinoma if cirrhosis is present
References
Gan EK, Powell LW, Olynyk JK. Natural history and management of HFE-hemochromatosis. Semin Liver Dis. 2011;31:293–301.
Alexander J, Kowdley K. HFE-associated hereditary hemochromatosis. Genet Med. 2009;11:307–11.
Deugnier Y, Brissot P, Loreal O. Iron and the liver: update 2008. J Hepatol. 2008;48:S113–23.
Babitt JL, Lin HY. The molecular pathogenesis of hereditary hemochromatosis. Semin Liver Dis. 2011;31:280–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Qureshi, M., Forouhar, F. (2013). Hereditary Hemochromatosis: Gastrointestinal Features. In: Wu, G., Selsky, N., Grant-Kels, J. (eds) Atlas of Dermatological Manifestations of Gastrointestinal Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6191-3_71
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6191-3_71
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6190-6
Online ISBN: 978-1-4614-6191-3
eBook Packages: MedicineMedicine (R0)